The phase 2 trial included a separate arm specifically for people with type 2 diabetes
The STEP trials demonstrated that semaglutide produces sustained weight loss of 15-22% over 68 weeks in people with overweight or obesity, while the SURMOUNT trials showed tirzepatide delivering even greater reductions of 20-22% at standard doses
Working means your weight trend is moving toward your goal, and the receipt is right underneath: "Down 6.4 lbs over the last 28 days
Challenging questionable claims
Hyperalgesia is an increased pain response to stimuli that do normally cause pain, such as a pinch hurting far more than expected
Chu J, Zhang H, Wu Y, Huang Y, Zhu T, Zhou Z, Wang H